Skip to main content

J&J says its Covid vaccine booster shot generated a promising immune response in early trials

J&J's booster dose generated virus-fighting antibodies "nine-fold higher" than those seen four weeks after the first dose, the company said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.